Vimian Group AB (OSTO:VIMIAN) Total Noninterest Expense

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:VIMIAN Vimian Group AB OSTO:VIMIAN
76 GF Score
Price kr34.20
GF Value kr36.06
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Vimian Group AB Total Noninterest Expense?

Total Noninterest Expense only applies to banks.

OSTO:VIMIAN
76GF Score
Vimian Group AB OSTO:VIMIAN
Total Noninterest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vimian Group AB (OSTO:VIMIAN) Overvalued in 2026?

Based on GuruFocus' analysis, Vimian Group AB stock appears to be undervalued. The current stock price of kr34.20 is trading 5.2% below its estimated GF Value™ of kr36.06. GuruFocus considers Vimian Group AB to be Fairly Valued.

Key valuation signals for OSTO:VIMIAN:

  • Total Noninterest Expense:
  • GF Value™: kr36.06 vs. price of kr34.20 (5.2% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the OSTO:VIMIAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vimian Group AB Business Description

Other Exchanges VIMIAs:UK0V0:Germany
Address Riddargatan 19, Stockholm, SWE, SE-11457
Vimian Group AB specializes in the areas of animal health, such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals, with a position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.
76GF Score

Get the complete analysis for OSTO:VIMIAN

Total Noninterest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr34.20
Price
kr36.06
GF Value